Cyclerion Therapeutics (NASDAQ:CYCN) Stock Price Down 6.2%

Cyclerion Therapeutics Inc (NASDAQ:CYCN) fell 6.2% during mid-day trading on Thursday . The stock traded as low as $1.79 and last traded at $1.82, 682,400 shares changed hands during mid-day trading. An increase of 152% from the average session volume of 270,909 shares. The stock had previously closed at $1.94.

The company’s 50 day simple moving average is $7.76 and its 200-day simple moving average is $10.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 6.32 and a quick ratio of 6.60.

Institutional investors and hedge funds have recently made changes to their positions in the company. Broderick Brian C purchased a new stake in shares of Cyclerion Therapeutics during the third quarter valued at $399,000. First Trust Advisors LP purchased a new stake in shares of Cyclerion Therapeutics during the third quarter valued at $430,000. California Public Employees Retirement System purchased a new stake in shares of Cyclerion Therapeutics during the third quarter valued at $404,000. Finally, Russell Investments Group Ltd. purchased a new stake in shares of Cyclerion Therapeutics during the third quarter valued at $1,112,000. 71.38% of the stock is currently owned by hedge funds and other institutional investors.

Cyclerion Therapeutics Company Profile (NASDAQ:CYCN)

There is no company description available for Cyclerion Therapeutics Inc

Featured Story: What Are Treasury Bonds?

Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.